| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $437.4M | +72.2% |
| R&D Expense | $66.8M | +40.7% |
| SG&A Expense | $278.2M | +64.7% |
| Operating Income | -$129.1M | -12.3% |
| Pre-tax Income | -$117.5M | -2.2% |
| Income Tax | -$2.1M | -985.0% |
| Net Income | -$65.6M | -81.7% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $38.9M | -86.1% |
| Accounts Receivable | $1.2M | -78.1% |
| Current Assets | $741.6M | +13.6% |
| Total Assets | $1.04B | +27.7% |
| Current Liabilities | $397.5M | +50.2% |
| Total Liabilities | $526.6M | +92.7% |
| Stockholders' Equity | $291.1M | +4.8% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $168.3M | +141.5% |
| Capital Expenditures | $31.4M | +11.4% |
| Investing Cash Flow | -$359.6M | +10.8% |
| Financing Cash Flow | -$48.9M | -109.7% |
| Free Cash Flow | $136.9M | +229.5% |